 MINNEAPOLIS, Feb. 02, 2021 GLOBE NEWSWIRE -- Predictive Oncology Inc. NASDAQ: POAI Predictive Oncology or the Company, a knowledge-driven company focused on applying artificial intelligence AI to personalized medicine and drug discovery, today announced that based on a notification letter recently received from the Listing Qualifications Department of the Nasdaq Stock Market Inc. the Nasdaq, the Company has regained compliance with the minimum bid price requirement set forth in Rule 5550a2 of the Nasdaq Listing Rules the Minimum Bid Price Requirement. 